CliffBio
small molecule

CLARINEX-D 12 HOUR

DESLORATADINE; PSEUDOEPHEDRINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLARINEX-D 12 HOUR
Active ingredientDESLORATADINE; PSEUDOEPHEDRINE SULFATE
Strength2.5MG;120MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2006
Marketing statusRX

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLARINEX-D 12 HOUR patent cliff — loss of exclusivity — | CliffBio